Recent Blog Posts
Five reasons why we should invest in women-owned businesses
In the pursuit of inclusive economic growth, one of the most important avenues to explore is the support of women-owned businesses. Across the globe, women entrepreneurs are not just contributors to economies, they are agents of change, driving innovation, creating...
Strategies for the future of clinical research: decentralised clinical trials
Challenges with traditional clinical trials The traditional clinical trials system acts as a quality funnel for the development and implementation of new drugs, devices and health system interventions. They are centred around the trial site(s). The trial protocols...
Newsletter March 2024
#CountAfricaIn in the field of clinical research Pharmalys team takes the floor! Pharmalys team members give their feedback on how to improve the Pharmalys Voice concept Introduced in March 2023, Pharmalys Voice represents a recurrent team gathering designed...
The underrepresentation of racial and ethnic minority groups in randomised controlled clinical trials limits the generalisability of healthcare findings
In recent years, growing concern has been raised regarding the lack of diversity in health and clinical research trials. As an increasing number of studies investigate the underrepresentation of racial and ethnic minority groups in health research, a notable discourse...
Continuous Excellence – Soft Skills Training Programme
Excellence is Pharmalys’ creed At Pharmalys, we foster a culture of excellence. Excellence defines our mission to help advance health through data excellence; it drives our daily work, it characterises of our relationships with customers Accueil | Pharmalys. In...
Supporting and expanding the Clinical Research ecosystem in Africa is part of Pharmalys’ mission
Capacity building programme AMELIORER, in Benin The clinical research context in Africa With continued interest in advancing clinical trial conduct in sub-Saharan Africa, there is a growing imperative to strengthen pharmacovigilance systems, develop and reinforce the...
Capacity building programme in Côte d’Ivoire, October 2023
The Côte d'ivoire Ethics Capacity Building Initiative (CECaBI) is a consortium of different partners whose objectives are to strengthen the knowledge and skills of the senior members of the National Ethics Committee for Life Sciences and Ivorian Authorities of...
Capacity building programme in The Gambia, October 2023
Beginning of October 2023, Dr. Karim Bagaté, Director of Clinical Operations & Safety, and Mr. Assane Ndiaye, Clinical Research Associates Manager at Pharmalys delivered a capacity building programme, named ERC (Ethics and Regulatory Capacity) in The Gambia. The...
Newsletter october 2023
Welcome to the October edition of the Pharmalys Newsletter! Pharmalys continues its dynamic growth! Since the beginning of 2023, we have expanded our global Pharmalys family, welcoming new colleagues in IT, Clinical Operations, Drug safety, Business Excellence...
Pharmalys Business Excellence Philosophy
Pharmalys Limited is a Contract Research Organisation that was first established in London, UK in 2008. We have extensive experience leading the design, execution and reporting of clinical trial programs that meet global health authority quality and ethical standards...